MS, Disease-Modifying Drugs, and the Risk for Adverse Perinatal and Pregnancy Outcomes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Multiple sclerosis, disease-modifying drugs and risk for adverse perinatal and pregnancy outcomes: Results from a population-based cohort study
Mult. Scler. 2023 Apr 18;[EPub Ahead of Print], K Fink, A Gorczyca, P Alping, S Englund, S Farmand, AM Langer-Gould, F Piehl, K McKay, T Frisell, N RazazFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.